We also use optional cookies for advertising, personalisation of content, usage analysis, and social media. By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with...
About SelectHub (and our data) We’re the employee-owned Austin-based startup democratizing software data so you can make your decisions in an influence-free zone. Our market data is crowdsourced from our user-base of 100,000+ companies....
Your most trusted source for clinical reviews – now full text online! - ScienceDirectdoi:10.1016/S1096-2883(04)00083-XTechniques in Gastrointestinal Endoscopy
Help shape the software you use every day Collaboration is a core value at Advarra, and every major development project is completed in close collaboration with the organizations that benefit from our software. Stay connected with your peers ...
Financial impediments have affected the conduct ofVADclinical trials profoundly. The issue of funding is central because device companies are often innovative organizations with limited cash reserves and few sources of income. Shrinking budgets for academic centers limit their resources in the face of th...
higher-risk product reviews. companies that receive pre-certification status will be required to demonstrate consistent and reliably high-quality software design and validation and ongoing maintenance of their software products. 15 the fda has selected nine companies to participate in the ...
CiteSpace is a software package that provides researchers with several scientometric analyses to assess the development of a specific field [42]. Additionally, VOSviewer is a software tool that facilitates the visualisation and mapping of scientific domains. CiteSpace provides fewer scientometric analysis...
For more than 35 years, research using CPRD data and services has informed clinical guidance and best practice, resulting inover 3,500 peer-reviewed publicationsinvestigating drug safety, use of medicines, effectiveness of health policy, health care delivery and disease risk factors. ...
For trials permitting crossover, pharmaceutical companies are frequently using crossover as the main reason why a surrogate endpoint, such as progression-free survival or tumor response, yet not the clinical endpoint, e.g., overall survival, showed a significant result [38]. Scholars increasingly ...
Prior research on online reviews of physicians is rather limited and does not cover chronic diseases in general, Lahiri said. According to the Centers for Disease Control and Prevention, 90% of the $3.5 trillion that the U.S. spends annually on health care goes toward patients withchronic cond...